en

PRODUCT DETAIL

Zonisamide Neuraxpharm 300 mg tablety

Code 1515E
MA number 21/0196/22-S
Product Form: tbl 196x300 mg (blis.PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX15 Zonisamide
Shelf life: 24
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 30.07.2022
Validity: 30.07.2027
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Zonisamide Neuraxpharm 25 mg, 50 mg, 100 mg, 200 mg, 300 mg tbl_07 2022.pdf  
SPC: SPC_Zonisamide Neuraxpharm 25 mg, 50 mg, 100 mg, 200 mg, 300 mg tbl_07 2022.pdf  
Safety feature Unknown
Data update: 09.08.2022
eu-flag.png sk-flag.png